Lyme Disease IgG/IgM Ab
Lyme Disease IgG/IgM Ab is a clinical biomarker on the Infection panel, reported in index. Standard reference range: 0–1.09 index. Functional (optimal) range used by integrative practitioners: 0–0 index.
What is Lyme Disease IgG/IgM Ab?
Lyme disease IgG/IgM screening detects antibodies to Borrelia burgdorferi; a positive result requires confirmatory Western blot testing per CDC two-tier criteria.
Reference ranges
| Range type | Value (index) | Source |
|---|---|---|
| Standard (lab) | 0–1.09 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 0–0 | Integrative / functional medicine consensus |
How SomaVue interprets Lyme Disease IgG/IgM Ab
SomaVue maps every result for Lyme Disease IgG/IgM Ab against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for Lyme Disease IgG/IgM Ab and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.